相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。HIF-1α and CA IX staining in invasive breast carcinomas:: Prognosis and treatment outcome
Cynthia Trastour et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Tumor carbonic anhydrase 9 expression is associated with the presence of lymph node metastases in uterine cervical cancer
Sun Lee et al.
CANCER SCIENCE (2007)
Sorafenib in advanced clear-cell renal-cell carcinoma
Bernard Escudier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Sunitinib versus interferon alfa in metastatic renal-cell carcinoma
Robert J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Cancer statistics, 2007
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2007)
Vascular cell adhesion molecule 1 predicts cancer-free survival in clear cell renal carcinoma patients
Ko-ichi Shioi et al.
CLINICAL CANCER RESEARCH (2006)
Role of carbonic anhydrases in the progression of renal cell carcinoma subtypes: Proposal of a unified hypothesis
Thambi Dorai et al.
CANCER INVESTIGATION (2006)
Clinical response to therapy targeted at vascular endothelial growth factor in metastatic renal cell carcinoma: impact of patient characteristics and Von Hippel-Lindau gene status
Brian I. Rini et al.
BJU INTERNATIONAL (2006)
Mammalian target of rapamycin inhibitors in renal cell carcinoma: Current status and future applications
Allan J. Pantuck et al.
SEMINARS IN ONCOLOGY (2006)
Expression of carbonic anhydrase IX (CA IX), a hypoxia-related protein, rather than vascular-endothelial growth factor (VEGF), a pro-angiogenic factor, correlates with an extremely poor prognosis in esophageal and gastric adenocarcinomas
A Driessen et al.
ANNALS OF SURGERY (2006)
Expression of carbonic anhydrase IX in astrocytic tumors predicts poor prognosis
JA Haapasalo et al.
CLINICAL CANCER RESEARCH (2006)
Expression of carbonic anhydrase 9 at the invasion front of gastric cancers
J Chen et al.
GUT (2005)
Loss of expression of von Hippel-Lindau tumor suppressor protein associated with improved survival in patients with early-stage clear cell, renal cell carcinoma
AS Parker et al.
UROLOGY (2005)
Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer
M Atkins et al.
CLINICAL CANCER RESEARCH (2005)
A phase II trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patients
I Bleumer et al.
BRITISH JOURNAL OF CANCER (2004)
Role of VHL gene mutation in human cancer
WY Kim et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Carbonic anhydrase IX as a marker for poor prognosis in soft tissue sarcoma
K Måseide et al.
CLINICAL CANCER RESEARCH (2004)
Carbonic anhydrase-9 expression levels and prognosis in human breast cancer: association with treatment outcome
PN Span et al.
BRITISH JOURNAL OF CANCER (2003)
Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer
DEB Swinson et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
The genetic basis of cancer of the kidney
WM Linehan et al.
JOURNAL OF UROLOGY (2003)
Comprehensive mutational analysis of the VHL gene in sporadic renal cell carcinoma:: Relationship to clinicopathological parameters
K Kondo et al.
GENES CHROMOSOMES & CANCER (2002)
VHL mutations and their correlation with tumour cell proliferation, microvessel density, and patient prognosis in clear cell renal cell carcinoma
P Schraml et al.
JOURNAL OF PATHOLOGY (2002)
Tumor hypoxia:: Definitions and current clinical, biologic, and molecular aspects
M Höckel et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Up-regulation of hypoxia-inducible factors HIF-1α and HIF-2α under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function
M Krieg et al.
ONCOGENE (2000)
Hypoxia inducible factor-α binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein
ME Cockman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
分享论文
